Although Foxp3+ regulatory T cells (Tregs) require interleukin-2 (IL-2) for their development, it has been unclear whether continuing IL-2 signals are needed to maintain lineage stability, survival, and suppressor function in mature Tregs. We generated mice in which CD25, the main ligand-binding subunit of the IL-2 receptor, can be inducibly deleted from Tregs after thymic development. In contrast to Treg development, we find that IL-2 is dispensable for maintaining lineage stability in mature Tregs. Although continuous IL-2 signaling is needed for long-term Treg survival, CD25-deleted Tregs may persist for several weeks in vivo using IL-7. We also observe defects in glycolytic metabolism and suppressor function following CD25 deletion. Thus, unlike developing Tregs in which the primary role of IL-2 is to initiate Foxp3 expression, mature Tregs require continuous IL-2 signaling to maintain survival and suppressor function, but not to maintain lineage stability.
Pubmed ID: 30380412 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
THIS RESOURCE IS NO LONGER IN SERVICE. Documented on May 5,2022.Tool that predicts interactions between transcription factors and their regulated genes from binding motifs. Understanding vertebrate development requires unraveling the cis-regulatory architecture of gene regulation. PRISM provides accurate genome-wide computational predictions of transcription factor binding sites for the human and mouse genomes, and integrates the predictions with GREAT to provide functional biological context. Together, accurate computational binding site prediction and GREAT produce for each transcription factor: 1. putative binding sites, 2. putative target genes, 3. putative biological roles of the transcription factor, and 4. putative cis-regulatory elements through which the factor regulates each target in each functional role.
View all literature mentionsThis monoclonal targets CD28
View all literature mentionsThis monoclonal targets CD3epsilon
View all literature mentionsThis monoclonal targets CD154
View all literature mentionsThis unknown targets Human PTEN
View all literature mentionsThis polyclonal targets
View all literature mentionsThis monoclonal targets Phospho-ERK1/2 (Thr202, Tyr204)
View all literature mentionsThis monoclonal targets Phospho-AKT1 (Ser473)
View all literature mentionsThis monoclonal targets Phospho-S6 (Ser235, Ser236)
View all literature mentionsThis monoclonal targets Phospho-STAT5 (Tyr694)
View all literature mentionsThis monoclonal targets FOXP3
View all literature mentionsThis monoclonal targets Helios
View all literature mentionsThis monoclonal targets CD215 (IL-15Ra)
View all literature mentionsThis monoclonal targets CD25
View all literature mentionsThis monoclonal targets CD304
View all literature mentionsThis monoclonal targets CD152
View all literature mentionsThis monoclonal targets CD357
View all literature mentionsThis monoclonal targets CD278
View all literature mentionsThis monoclonal targets CD279
View all literature mentionsThis monoclonal targets CD132
View all literature mentionsThis monoclonal targets CD122
View all literature mentionsThis monoclonal targets CD127
View all literature mentionsThis monoclonal targets CD31
View all literature mentionsThis monoclonal targets CD69
View all literature mentionsThis monoclonal targets CD44
View all literature mentionsThis monoclonal targets CD62L
View all literature mentionsThis monoclonal targets CD45.1
View all literature mentionsThis monoclonal targets CD45.2
View all literature mentionsThis monoclonal targets CD8a
View all literature mentionsThis monoclonal targets CD4
View all literature mentionsThis monoclonal targets CD25
View all literature mentionsThis monoclonal targets CD28
View all literature mentionsThis monoclonal targets CD154
View all literature mentionsThis monoclonal targets CD3epsilon
View all literature mentionsThis unknown targets Human PTEN
View all literature mentionsThis polyclonal targets
View all literature mentionsThis monoclonal targets Phospho-ERK1/2 (Thr202, Tyr204)
View all literature mentionsThis monoclonal targets Phospho-STAT5 (Tyr694)
View all literature mentionsThis monoclonal targets Phospho-AKT1 (Ser473)
View all literature mentionsThis monoclonal targets Phospho-S6 (Ser235, Ser236)
View all literature mentionsThis monoclonal targets CD25
View all literature mentionsThis monoclonal targets CD304
View all literature mentionsThis monoclonal targets CD152
View all literature mentionsThis monoclonal targets CD357
View all literature mentionsThis monoclonal targets FOXP3
View all literature mentionsThis monoclonal targets CD278
View all literature mentionsThis monoclonal targets CD279
View all literature mentionsThis monoclonal targets Helios
View all literature mentionsThis monoclonal targets CD132
View all literature mentionsThis monoclonal targets CD122
View all literature mentionsThis monoclonal targets CD215 (IL-15Ra)
View all literature mentionsThis monoclonal targets CD127
View all literature mentionsThis monoclonal targets CD31
View all literature mentionsThis monoclonal targets CD62L
View all literature mentionsThis monoclonal targets CD69
View all literature mentionsThis monoclonal targets CD44
View all literature mentionsThis monoclonal targets CD45.1
View all literature mentionsThis monoclonal targets CD45.2
View all literature mentionsThis monoclonal targets CD8a
View all literature mentionsThis monoclonal targets CD4
View all literature mentionsThis monoclonal targets CD127
View all literature mentions